<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
<channel>
<title>Yahoo! News: Business - Pharmaceutical</title>
<copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright>
<link>http://news.yahoo.com/i/1190</link>
<category>business</category>
<description>Business - Pharmaceutical</description>
<language>en-us</language> 
<lastBuildDate>Wed, 01 Jul 2009 04:16:11 GMT</lastBuildDate>
<ttl>5</ttl> 
<image>
<title>Yahoo! News</title>
<width>142</width>
<height>18</height>
<link>http://news.yahoo.com/i/1190</link>
<url>http://l.yimg.com/a/i/us/nws/th/main_142b.gif</url>
</image>
<item>
<title>U.S. group questions AstraZeneca&#39;s Crestor patent 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090701/bs_nm/us_astrazeneca_patent</link>
 <guid isPermaLink="false">nm/20090701/us_astrazeneca_patent</guid>
<source>Reuters</source>
<category>business</category>
<pubDate>Wed, 01 Jul 2009 04:16:11 GMT</pubDate>
<description>Reuters - A U.S. patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc&#39;s  patent for its cholesterol fighter Crestor invalid.</description>
</item>
<item>
<title>FDA panel: Lower maximum daily dose of Tylenol 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090701/ap_on_bi_ge/us_tylenol_safety_fda</link>
 <guid isPermaLink="false">ap/20090701/us_tylenol_safety_fda</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 01 Jul 2009 02:51:02 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090701/ap_on_bi_ge/us_tylenol_safety_fda">&#60;img src="http://d.yimg.com/a/p/ap/20090630/capt.a2c4cf98ffb44685baa4938e15d085cf.tylenol_safety_fda_masr103.jpg?x=130&amp;y=127&amp;q=85&amp;sig=H71jgiFIcbYdkB1.iivKOA--" align="left" height="127" width="130" alt="A bottle of Tylenol, which contains the ingredient acetaminophen, appears with its box wrapper, in Walpole, Mass., Tuesday, June 30, 2009. In a series of votes Tuesday, a Food and Drug Administration panel endorsed lowering the maximum dose of over-the-counter acetaminophen &#151; the key ingredient in Tylenol, Excedrin and other medications. (AP Photo/Steven Senne)" border="0" />&#60;/a>AP - Government experts called for sweeping safety restrictions Tuesday on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/ap/20090630/capt.a2c4cf98ffb44685baa4938e15d085cf.tylenol_safety_fda_masr103.jpg?x=130&amp;y=127&amp;q=85&amp;sig=H71jgiFIcbYdkB1.iivKOA--" type="image/jpeg" height="127" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090701/ap_on_bi_ge/us_tylenol_safety_fda">&#60;img src="http://d.yimg.com/a/p/ap/20090630/capt.a2c4cf98ffb44685baa4938e15d085cf.tylenol_safety_fda_masr103.jpg?x=130&amp;y=127&amp;q=85&amp;sig=H71jgiFIcbYdkB1.iivKOA--" align="left" height="127" width="130" alt="photo" title="A bottle of Tylenol, which contains the ingredient acetaminophen, appears with its box wrapper, in Walpole, Mass., Tuesday, June 30, 2009. In a series of votes Tuesday, a Food and Drug Administration panel endorsed lowering the maximum dose of over-the-counter acetaminophen &#151; the key ingredient in Tylenol, Excedrin and other medications. (AP Photo/Steven Senne)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AP)</media:credit>
</item>
<item>
<title>Pfizer discontinues Sutent colon cancer study 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090630/ap_on_bi_ge/us_pfizer_sutent_study</link>
 <guid isPermaLink="false">ap/20090630/us_pfizer_sutent_study</guid>
<source>AP</source>
<category>business</category>
<pubDate>Tue, 30 Jun 2009 21:26:14 GMT</pubDate>
<description>AP - Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough.</description>
</item>
<item>
<title>Teva, Antares get FDA OK for hormone in new device 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090629/ap_on_bi_ge/us_teva_antares_product</link>
 <guid isPermaLink="false">ap/20090629/us_teva_antares_product</guid>
<source>AP</source>
<category>business</category>
<pubDate>Mon, 29 Jun 2009 20:11:33 GMT</pubDate>
<description>AP - Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. said Monday the companies received Food and Drug Administration approval for use of the human growth hormone Tev-Tropin in a needle-free injection system.</description>
</item>
<item>
<title>Dogs helping injured soldiers under gov&#039;t program 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090628/ap_on_re_us/us_wounded_warriors_dogs</link>
 <guid isPermaLink="false">ap/20090628/us_wounded_warriors_dogs</guid>
<source>AP</source>
<category>us</category>
<pubDate>Sun, 28 Jun 2009 17:12:19 GMT</pubDate>
<description>AP - Army Specialist Cameron Briggs washes down a cocktail of prescription drugs every day for post-traumatic stress disorder and a brain injury he suffered when four roadside bombs rocked his Humvee in Iraq.</description>
</item>
<item>
<title>Prescription drugs in spotlight after Jackson death 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090628/ts_alt_afp/entertainmentusmusicjacksondrugs</link>
 <guid isPermaLink="false">afp/20090628/entertainmentusmusicjacksondrugs</guid>
<source>AFP</source>
<category>us</category>
<pubDate>Sun, 28 Jun 2009 01:38:00 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090628/ts_alt_afp/entertainmentusmusicjacksondrugs">&#60;img src="http://d.yimg.com/a/p/afp/20090628/capt.photo_1246152985329-1-0.jpg?x=130&amp;y=93&amp;q=85&amp;sig=TfKMoptoLaWR4RvMFiIHGg--" align="left" height="93" width="130" alt="View of outside the County of Los Angeles Coroners office, on June 26. Michael Jackson&#39;s cause of death would not be confirmed for several weeks, according to officials, as attention has turned to the possible involvement of drugs in the tragic King of Pop&#39;s demise.(AFP/Gabriel Bouys)" border="0" />&#60;/a>AFP - Michael Jackson&#39;s death has lifted a veil on the sinister underbelly of fame, with associates of the pop icon hitting out at celebrity-dazzled doctors who funnel powerful narcotics to the stars.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/afp/20090628/capt.photo_1246152985329-1-0.jpg?x=130&amp;y=93&amp;q=85&amp;sig=TfKMoptoLaWR4RvMFiIHGg--" type="image/jpeg" height="93" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090628/ts_alt_afp/entertainmentusmusicjacksondrugs">&#60;img src="http://d.yimg.com/a/p/afp/20090628/capt.photo_1246152985329-1-0.jpg?x=130&amp;y=93&amp;q=85&amp;sig=TfKMoptoLaWR4RvMFiIHGg--" align="left" height="93" width="130" alt="photo" title="View of outside the County of Los Angeles Coroners office, on June 26. Michael Jackson&#39;s cause of death would not be confirmed for several weeks, according to officials, as attention has turned to the possible involvement of drugs in the tragic King of Pop&#39;s demise.(AFP/Gabriel Bouys)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
<item>
<title>FDA panel backs Ista drug for eye allergies 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090626/ap_on_bi_ge/us_ista_pharmaceuticals_fda</link>
 <guid isPermaLink="false">ap/20090626/us_ista_pharmaceuticals_fda</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 26 Jun 2009 19:59:37 GMT</pubDate>
<description>AP - A panel of federal experts said Friday an anti-itching drug from eye care company Ista Pharmaceuticals is safe and effective, according to a government spokeswoman.</description>
</item>
<item>
<title>U.S. seizes Caraco drugs over manufacturing problems 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090625/us_nm/us_caraco_fda</link>
 <guid isPermaLink="false">nm/20090625/us_caraco_fda</guid>
<source>Reuters</source>
<category>us</category>
<pubDate>Thu, 25 Jun 2009 20:00:15 GMT</pubDate>
<description>Reuters - U.S. authorities seized generic medicines made by Caraco Pharmaceutical Laboratories Ltd at plants in Michigan following repeated violations of manufacturing standards, regulators said on Thursday.</description>
</item>
<item>
<title>Watson gets FDA approval for generic Plan B 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090624/ap_on_bi_ge/us_watson_pharmaceuticals_fda</link>
 <guid isPermaLink="false">ap/20090624/us_watson_pharmaceuticals_fda</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 24 Jun 2009 22:06:35 GMT</pubDate>
<description>AP - Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals&#039; Plan B emergency contraceptive.</description>
</item>
<item>
<title>Drug deals cost U.S. consumers &#36;3.5 bln a year: FTC 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090623/us_nm/us_ftc_generic</link>
 <guid isPermaLink="false">nm/20090623/us_ftc_generic</guid>
<source>Reuters</source>
<category>us</category>
<pubDate>Tue, 23 Jun 2009 17:06:46 GMT</pubDate>
<description>Reuters - Consumers, insurance companies and the federal government spend an extra &#36;3.5 billion for prescription drugs every year because brand-name companies pay generic producers to stay out of the market, the head of the U.S. Federal Trade Commission said on Tuesday.</description>
</item>
<item>
<title>Obama announces agreement with drug companies 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090622/ap_on_bi_ge/us_obama_drugs</link>
 <guid isPermaLink="false">ap/20090622/us_obama_drugs</guid>
<source>AP</source>
<category>business</category>
<pubDate>Mon, 22 Jun 2009 16:28:26 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090622/ap_on_bi_ge/us_obama_drugs">&#60;img src="http://d.yimg.com/a/p/rids/20090617/i/r888189926.jpg?x=130&amp;y=86&amp;q=85&amp;sig=zpIHthFQ7dpsKu6VZL2wnA--" align="left" height="86" width="130" alt="President Barack Obama delivers remarks on the health care system at the annual meeting of the American Medical Association in Chicago, Illinois, June 15, 2009. REUTERS/Jonathan Ernst" border="0" />&#60;/a>AP - President Barack Obama on Monday welcomed the pharmaceutical industry&#039;s agreement to help close a gap in Medicare&#039;s drug coverage, calling the pact a step forward in the push for overhaul of the health care system.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/rids/20090617/i/r888189926.jpg?x=130&amp;y=86&amp;q=85&amp;sig=zpIHthFQ7dpsKu6VZL2wnA--" type="image/jpeg" height="86" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090622/ap_on_bi_ge/us_obama_drugs">&#60;img src="http://d.yimg.com/a/p/rids/20090617/i/r888189926.jpg?x=130&amp;y=86&amp;q=85&amp;sig=zpIHthFQ7dpsKu6VZL2wnA--" align="left" height="86" width="130" alt="photo" title="President Barack Obama delivers remarks on the health care system at the annual meeting of the American Medical Association in Chicago, Illinois, June 15, 2009. REUTERS/Jonathan Ernst" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AP)</media:credit>
</item>
<item>
<title>Baucus, White House in deal with drug industry 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090620/ap_on_bi_ge/us_health_overhaul</link>
 <guid isPermaLink="false">ap/20090620/us_health_overhaul</guid>
<source>AP</source>
<category>business</category>
<pubDate>Sat, 20 Jun 2009 21:09:07 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090620/ap_on_bi_ge/us_health_overhaul">&#60;img src="http://d.yimg.com/a/p/ap/20090619/capt.b2bfadb300f74441ab5998c7be6eace0.health_overhaul_wx105.jpg?x=104&amp;y=130&amp;q=85&amp;sig=pxiV2mwrPH8_Wwj0S2fR.w--" align="left" height="130" width="104" alt="FILE - In this April 2, 2009 file photo, Senate Finance Committee Chairman Sen. Max Baucus, D-Mont., left, and the committee&#039;s ranking Republican Sen. Charles Grassley, R-Iowa talk on Capitol Hill in Washington.  (AP Photo/Susan Walsh, FILE)" border="0" />&#60;/a>AP - The pharmaceutical industry agreed Saturday to spend &#36;80 billion over the next decade improving drug benefits for seniors on Medicare and defraying the cost of President Barack Obama&#039;s health care legislation, capping secretive negotiations with the White House and key lawmakers.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/ap/20090619/capt.b2bfadb300f74441ab5998c7be6eace0.health_overhaul_wx105.jpg?x=104&amp;y=130&amp;q=85&amp;sig=pxiV2mwrPH8_Wwj0S2fR.w--" type="image/jpeg" height="130" width="104"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090620/ap_on_bi_ge/us_health_overhaul">&#60;img src="http://d.yimg.com/a/p/ap/20090619/capt.b2bfadb300f74441ab5998c7be6eace0.health_overhaul_wx105.jpg?x=104&amp;y=130&amp;q=85&amp;sig=pxiV2mwrPH8_Wwj0S2fR.w--" align="left" height="130" width="104" alt="photo" title="FILE - In this April 2, 2009 file photo, Senate Finance Committee Chairman Sen. Max Baucus, D-Mont., left, and the committee&#039;s ranking Republican Sen. Charles Grassley, R-Iowa talk on Capitol Hill in Washington.  (AP Photo/Susan Walsh, FILE)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AP)</media:credit>
</item>
<item>
<title>&#039;Data mining&#039; for drug companies goes to courts 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090619/ap_on_re_us/us_drug_data_mining</link>
 <guid isPermaLink="false">ap/20090619/us_drug_data_mining</guid>
<source>AP</source>
<category>us</category>
<pubDate>Fri, 19 Jun 2009 23:33:21 GMT</pubDate>
<description>AP - The prescription drugs you take are on the minds of a lot of people: judges on two federal courts, legislators in several states, countless doctors and, at the center, the companies that make money by figuring out who&#039;s prescribing what.</description>
</item>
<item>
<title>Par announces mixed offering for &#36;150 million 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090619/ap_on_bi_ge/us_par_stock_offering</link>
 <guid isPermaLink="false">ap/20090619/us_par_stock_offering</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 19 Jun 2009 20:49:08 GMT</pubDate>
<description>AP - Par Pharmaceutical Cos. said Friday it is selling up to &#36;150 million in a mixed shelf offering and plans to use the proceeds for general corporate purposes.</description>
</item>
<item>
<title>China ends nine-month IPO ban 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090619/bs_afp/chinastocksipocompany</link>
 <guid isPermaLink="false">afp/20090619/chinastocksipocompany</guid>
<source>AFP</source>
<category>business</category>
<pubDate>Fri, 19 Jun 2009 06:14:03 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090619/bs_afp/chinastocksipocompany">&#60;img src="http://d.yimg.com/a/p/afp/20090619/capt.photo_1245385867388-1-0.jpg?x=130&amp;y=82&amp;q=85&amp;sig=gfL8h8rDXIOM8vjaYoGyrg--" align="left" height="82" width="130" alt="The skyline of Beijing&#39;s central business district. China will end a nine-month ban on initial public offerings, or IPOs, with a share sale by Guilin Sanjin Pharmaceutical, the company has said in a statement.(AFP/File/Frederic J. Brown)" border="0" />&#60;/a>AFP - China will end a nine-month ban on initial public offerings, or IPOs, with a share sale by Guilin Sanjin Pharmaceutical, the company has said in a statement.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/afp/20090619/capt.photo_1245385867388-1-0.jpg?x=130&amp;y=82&amp;q=85&amp;sig=gfL8h8rDXIOM8vjaYoGyrg--" type="image/jpeg" height="82" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090619/bs_afp/chinastocksipocompany">&#60;img src="http://d.yimg.com/a/p/afp/20090619/capt.photo_1245385867388-1-0.jpg?x=130&amp;y=82&amp;q=85&amp;sig=gfL8h8rDXIOM8vjaYoGyrg--" align="left" height="82" width="130" alt="photo" title="The skyline of Beijing&#39;s central business district. China will end a nine-month ban on initial public offerings, or IPOs, with a share sale by Guilin Sanjin Pharmaceutical, the company has said in a statement.(AFP/File/Frederic J. Brown)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
<item>
<title>Witherspoon prescribed &#39;Pharm Girl&#39; 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090618/ts_alt_afp/entertainmentusfilmwitherspoon</link>
 <guid isPermaLink="false">afp/20090618/entertainmentusfilmwitherspoon</guid>
<source>AFP</source>
<category>us</category>
<pubDate>Thu, 18 Jun 2009 16:21:23 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090618/ts_alt_afp/entertainmentusfilmwitherspoon">&#60;img src="http://d.yimg.com/a/p/afp/20090618/capt.photo_1245342042143-1-0.jpg?x=98&amp;y=130&amp;q=85&amp;sig=Ci51p_vcwq1bPQPIhRuE6g--" align="left" height="130" width="98" alt="Oscar-winner Reese Witherspoon, seen here in March 2009, is to star in a new comedy about the pharmaceutical business &quot;Pharm Girl,&quot; entertainment industry reports said Thursday.(AFP/Getty Images/File/Jason Merritt)" border="0" />&#60;/a>AFP - Oscar-winner Reese Witherspoon is to star in a new comedy about the pharmaceutical business &quot;Pharm Girl,&quot; entertainment industry reports said Thursday.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/afp/20090618/capt.photo_1245342042143-1-0.jpg?x=98&amp;y=130&amp;q=85&amp;sig=Ci51p_vcwq1bPQPIhRuE6g--" type="image/jpeg" height="130" width="98"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20090618/ts_alt_afp/entertainmentusfilmwitherspoon">&#60;img src="http://d.yimg.com/a/p/afp/20090618/capt.photo_1245342042143-1-0.jpg?x=98&amp;y=130&amp;q=85&amp;sig=Ci51p_vcwq1bPQPIhRuE6g--" align="left" height="130" width="98" alt="photo" title="Oscar-winner Reese Witherspoon, seen here in March 2009, is to star in a new comedy about the pharmaceutical business &quot;Pharm Girl,&quot; entertainment industry reports said Thursday.(AFP/Getty Images/File/Jason Merritt)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
<item>
<title>Shire, J&amp;J win key drug data case at top EU court 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090618/bs_nm/us_pharmaceuticals_europe_court</link>
 <guid isPermaLink="false">nm/20090618/us_pharmaceuticals_europe_court</guid>
<source>Reuters</source>
<category>business</category>
<pubDate>Thu, 18 Jun 2009 10:11:17 GMT</pubDate>
<description>Reuters - Shire and Johnson &amp; Johnson won the backing of Europe&#39;s highest court on Thursday in their battle for data exclusivity against a generic rival for Alzheimer&#39;s drug Reminyl, the court said.</description>
</item>
<item>
<title>Watson Pharma to buy Arrow group for &#36;1.75B 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20090617/ap_on_bi_ge/us_watson_pharmaceuticals_arrow_group</link>
 <guid isPermaLink="false">ap/20090617/us_watson_pharmaceuticals_arrow_group</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 17 Jun 2009 22:07:32 GMT</pubDate>
<description>AP - Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for &#36;1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.</description>
</item>
<item>
<title>Nasdaq advances with tech, but banks curb Dow, S&amp;P 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090617/bs_nm/us_markets_stocks</link>
 <guid isPermaLink="false">nm/20090617/us_markets_stocks</guid>
<source>Reuters</source>
<category>business</category>
<pubDate>Wed, 17 Jun 2009 21:12:04 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090617/bs_nm/us_markets_stocks">&#60;img src="http://d.yimg.com/a/p/ap/20090703/capt.1caf3d22eb4545a4bd6da5c2c9385bcb.correction_hong_kong_world_markets_xkc103.jpg?x=130&amp;y=85&amp;q=85&amp;sig=HHgQOnFzmNtx3yCt46DUNQ--" align="left" height="85" width="130" alt="Floor traders work at the Hong Kong Stock Exchange Friday, July 3, 2009 in Hong Kong. Asian stocks retreated Friday as a weaker-than-expected U.S. jobs report signaled more pain ahead for the world&#039;s largest economy. Losses across Asia were somewhat tame compared to Wall Street, where markets pulled sharply lower. Oil prices weakened further, while the dollar was little changed against the yen. (AP Photo/Kin Cheung)" border="0" />&#60;/a>Reuters - Technology shares buoyed the Nasdaq on Wednesday after positive broker comments on Qualcomm, but financial shares&#39; losses held back the Dow and the S&amp;P 500.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/ap/20090703/capt.1caf3d22eb4545a4bd6da5c2c9385bcb.correction_hong_kong_world_markets_xkc103.jpg?x=130&amp;y=85&amp;q=85&amp;sig=HHgQOnFzmNtx3yCt46DUNQ--" type="image/jpeg" height="85" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090617/bs_nm/us_markets_stocks">&#60;img src="http://d.yimg.com/a/p/ap/20090703/capt.1caf3d22eb4545a4bd6da5c2c9385bcb.correction_hong_kong_world_markets_xkc103.jpg?x=130&amp;y=85&amp;q=85&amp;sig=HHgQOnFzmNtx3yCt46DUNQ--" align="left" height="85" width="130" alt="photo" title="Floor traders work at the Hong Kong Stock Exchange Friday, July 3, 2009 in Hong Kong. Asian stocks retreated Friday as a weaker-than-expected U.S. jobs report signaled more pain ahead for the world&#039;s largest economy. Losses across Asia were somewhat tame compared to Wall Street, where markets pulled sharply lower. Oil prices weakened further, while the dollar was little changed against the yen. (AP Photo/Kin Cheung)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>Watson to go global with &#36;1.75 billion Arrow buy 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20090617/bs_nm/us_watson</link>
 <guid isPermaLink="false">nm/20090617/us_watson</guid>
<source>Reuters</source>
<category>business</category>
<pubDate>Wed, 17 Jun 2009 15:31:09 GMT</pubDate>
<description>Reuters - Watson Pharmaceuticals Inc  said on Wednesday that it would buy privately held Arrow Group for &#36;1.75 billion, clinching a long-expected deal by the U.S. generic drugmaker to expand internationally.</description>
</item>
</channel>
</rss>
<!-- server fe55.news.sp1.yahoo.com -->

